CSI Market
Sign In | Register

Exact Sciences (EXAS) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access EXAS Annual Cash Flow →
Reviewing cash flow data across recent quarters allows users to assess how Exact Sciences adapts its cash strategy across cycles.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
12 Months 		(Sep 30 2025) (Jun 30 2025) (Mar 31 2025) (Dec 31 2024)
Operating Activities
Income-207.95
Depreciation & amortization124.88
Amortization of Other Assets96.70
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Restructuring & Impairment Charges34.01
Provision For Loan Losses Expensed0.00
Increase (Decrease) in Inventories-3.77
Research and Development in Process0.00
Gain (Loss) on Disposition of Property Plant Equipment0.00
Share-based Compensation217.67
Income (Loss) from Equity Method Investments0.00
Gains (Losses) on Extinguishment of Debt0.00
Deferred Revenue Revenue Recognized-
Debt Forgiveness Cash Flow Impact-
Amortization Of Deferred License Fees-
Amortization Of Other Long Term Liabilities-
Depreciation And Amortization Of Fixed Assets-
Increase Decrease In Amortization Of Premium On Short Term Investments-
Investment Income Amortization Of Premium-
Deferred Income Tax Expense Benefit Related To Acquisitions-
Gain Loss On Settlement Of Convertible Notes-
Operating Lease Expense20.25
Marketable Securities Realized Gain Loss-
Equity Securities Fv Ni Unrealized Gain Loss-
Acceleration Of Unvested Equity Post Combination Expense-
Loss On Settlement Of Convertible Notes-
Gain On Settlement Of Convertible Notes-
Research And Development Asset Acquired Other Than Through Business Combination Written Off6.82
Gain Loss On Contingent Consideration From Disposition Of Asset-21.12
Income taxes-1.54
Losses/ -gains on Investments net0.00
Increase (Decrease) in Accounts Receivable-48.89
Increase (Decrease) in Accounts Payable214.04
Accrued Expense0.00
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets0.00
Other Working Capital-11.01
Other Noncash Income (Expense)6.90
Other net0.00
Payments for (Proceeds from) Other Operating Activities-31.62
Discontinued operations0.00
Net Cash flow from Operating Activities491.44
Investing Activities
Capital Expenditures-134.66
Sale of Capital Items0.00
Proceeds from Sale and Maturity of Marketable Securities572.28
Payments to Acquire Marketable Securities-140.27
Real Estate Investments0.00
Proceeds From Sale Of Investments In Privately Held Companies-
Proceeds From Contingent Consideration Receivable27.97
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments to Acquire Other Investments-55.50
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Payments to Acquire Assets, Investing Activities-75.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Repayments of Accounts Receivable Securitization0.00
Payments for (Proceeds from) Other Investing Activities0.30
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities195.12
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments249.17
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock28.45
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net-615.71
Payments For Capital Lease Obligations-
Proceeds From Other Long Term Liabilities-
Payments On Mortgage Payable-
Restricted Cash-
Proceeds From Exercise Of Common Stock Options Net Of Cash Paid For Taxes0.08
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities-338.09
Effect of exchange rate on cash flow0.89
Discontinued operations0.00
Free Cash Flow356.78
Total Cash Flow349.36
4 historic quarters locked

Sign in to unlock the full Exact Sciences cash flow history.

Sign In Create Free Account

About Exact Sciences Corp Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001124140-25-000091

Figures are derived from filed reports and may be restated. Historical data is subject to revision.